Madrigal Pharmaceuticals annual operating margin
2012
2024
2025
Madrigal Pharmaceuticals Operating Margin Growth & History (MDGL)
Madrigal Pharmaceuticals's operating margin was −31.31% for fiscal 2025.
View full Madrigal Pharmaceuticals company overviewMadrigal Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −31.31% | +245.08 pp |
| 2024 | 2024-12-31 | −276.39% | +41180.07 pp |
| 2012 | 2012-12-31 | −41,456.46% | — |
Madrigal Pharmaceuticals quarterly operating margin
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15.46% | +6.72 pp |
| Q1 2026 | 2026-03-31 | −29.78% | +28.00 pp |
| Q4 2025 | 2025-12-31 | −18.56% | +46.28 pp |
| Q3 2025 | 2025-09-30 | −39.68% | +147.38 pp |
| Q2 2025 | 2025-06-30 | −22.18% | +1088.20 pp |
| Q1 2025 | 2025-03-31 | −57.79% | — |
| Q4 2024 | 2024-12-31 | −64.84% | — |
| Q3 2024 | 2024-09-30 | −187.06% | — |
| Q2 2024 | 2024-06-30 | −1,110.38% | — |
Madrigal Pharmaceuticals operating margin trends
Across the available reported history, Madrigal Pharmaceuticals's operating margin increased from −276.39% to −31.31%, a change of +245.08 percentage points. The latest reported quarter, Q2 2026, shows −15.46%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Madrigal Pharmaceuticals filings at SEC.gov ↗